Journal
EUROPEAN HEART JOURNAL SUPPLEMENTS
Volume 22, Issue I, Pages I32-I37Publisher
OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/suaa102
Keywords
NOAC; Atrial fibrillation; Cardioversion; Ablation Pacemaker; ICD
Categories
Funding
- Daiichi Sankyo Europe GmbH
Ask authors/readers for more resources
Over the last 10 years since the introduction of non-vitamin K antagonist oral anticoagulants (NOACs) into routine clinical practice our experience with these drugs has increased tremendously, also in the context of patients undergoing electrophysiology procedures. While some open questions remain, the available evidence indicates that for the majority of cases, these interventions can safely be performed on NOACs if study-based standard operating procedures are in place and followed. This review summarizes the most current trial evidence and guidelines on the use of NOACs for patients undergoing cardioversion, atrial fibrillation ablation, and device implantations, based on previous work of the author and others.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available